Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'

Go back to Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'
Amgen Inc (NASDAQ: AMGN) Delayed: 353.23 +6.22 (1.79%)
Previous Close $347.01    52 Week High $176.85 
Open $348.00    52 Week Low $133.64 
Day High $353.26    P/E 53.20 
Day Low $346.00    EPS $6.64 
Volume 963,639